🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/01/2004 | 45,71 | 46,15 | 45,29 | 46,07 | +0,79% | 1,88% | 7.468.677 |
| 28/01/2004 | 45,61 | 46,10 | 45,42 | 45,71 | +1,14% | 1,49% | 11.747.556 |
| 27/01/2004 | 45,56 | 45,61 | 45,10 | 45,19 | +0,34% | 1,13% | 10.181.320 |
| 26/01/2004 | 44,32 | 45,24 | 44,24 | 45,04 | +3,10% | 2,26% | 12.631.439 |
| 23/01/2004 | 44,00 | 44,21 | 43,61 | 43,68 | -0,72% | 1,37% | 7.673.351 |
| 22/01/2004 | 44,23 | 44,38 | 43,86 | 44,00 | -0,30% | 1,17% | 7.855.179 |
| 21/01/2004 | 43,99 | 44,23 | 43,89 | 44,13 | +0,59% | 0,76% | 9.069.497 |
| 20/01/2004 | 43,89 | 44,42 | 43,70 | 43,87 | -0,45% | 1,63% | 7.547.277 |
| 16/01/2004 | 44,04 | 44,13 | 43,84 | 44,07 | +0,57% | 0,67% | 7.062.577 |
| 15/01/2004 | 44,13 | 44,15 | 43,62 | 43,83 | -0,78% | 1,21% | 6.747.443 |
| 14/01/2004 | 43,65 | 44,17 | 43,53 | 44,17 | +1,36% | 1,46% | 6.398.354 |
| 13/01/2004 | 43,60 | 43,99 | 43,42 | 43,58 | -0,50% | 1,31% | 8.905.694 |
| 12/01/2004 | 44,18 | 44,27 | 43,44 | 43,80 | -2,61% | 1,88% | 13.857.599 |
| 09/01/2004 | 45,42 | 45,54 | 44,87 | 44,97 | -1,98% | 1,49% | 9.228.164 |
| 08/01/2004 | 45,75 | 45,88 | 45,35 | 45,88 | +0,52% | 1,15% | 8.032.920 |
| 07/01/2004 | 45,76 | 45,77 | 45,34 | 45,64 | +0,13% | 0,94% | 10.255.309 |
| 06/01/2004 | 45,81 | 45,89 | 45,37 | 45,58 | -0,48% | 1,12% | 8.366.079 |
| 05/01/2004 | 45,90 | 45,90 | 45,20 | 45,80 | +2,02% | 1,52% | 12.495.828 |
| 02/01/2004 | 46,64 | 46,64 | 44,52 | 44,90 | +1,84% | 4,54% | 11.674.615 |
| 31/12/2003 | 43,80 | 44,18 | 43,72 | 44,08 | +1,54% | 1,05% | 9.544.031 |
| 30/12/2003 | 43,60 | 43,64 | 43,27 | 43,42 | -0,42% | 0,83% | 6.311.685 |
| 29/12/2003 | 43,42 | 43,63 | 43,19 | 43,60 | +1,31% | 1,01% | 8.324.788 |
| 26/12/2003 | 42,85 | 43,09 | 42,85 | 43,03 | +0,36% | 0,56% | 1.982.921 |
| 24/12/2003 | 42,66 | 43,10 | 42,57 | 42,88 | +0,38% | 1,25% | 3.534.485 |
| 23/12/2003 | 42,35 | 42,72 | 42,13 | 42,72 | +1,27% | 1,40% | 8.109.738 |
| 22/12/2003 | 42,33 | 42,38 | 41,98 | 42,19 | -0,34% | 0,92% | 7.824.158 |
| 19/12/2003 | 42,61 | 42,67 | 42,10 | 42,33 | -0,54% | 1,34% | 9.504.207 |
| 18/12/2003 | 42,22 | 42,64 | 42,18 | 42,56 | +1,13% | 1,11% | 9.753.107 |
| 17/12/2003 | 42,16 | 42,22 | 41,74 | 42,08 | -0,07% | 1,15% | 7.353.082 |
| 16/12/2003 | 41,92 | 42,31 | 41,80 | 42,11 | +0,98% | 1,21% | 8.217.263 |